Latest cholesterol drug comes with a $14,600-a-year price tag By: MarketWatch December 14, 2015 at 15:25 PM EST Five things to know about Praluent, the cholesterol drug that was approved by the FDA this summer. Read More >> Related Stocks: Regeneron Pharmaceuticals UnitedHealth Group